CASP3 and camptodactyly-arthropathy-coxa vara-pericarditis syndrome: In conclusion, the IA injection of rhPRG4 may offer some benefit to young patients with CACP judging by the correlation between inhibition of caspase-3 activation in chondrocytes and the observed quadruped gait improvement in stance and propulsion in male mice.